152 related articles for article (PubMed ID: 35441662)
1. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
2. Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
Chen S; Redfors B; Nazif T; Kirtane A; Crowley A; Ben-Yehuda O; Kapadia S; Finn MT; Goel S; Lindman BR; Alu MC; Chau KH; Thourani VH; Vahl TP; Douglas PS; Kodali SK; Leon MB
Eur Heart J; 2020 Feb; 41(8):943-954. PubMed ID: 31711153
[TBL] [Abstract][Full Text] [Related]
3. Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis.
Amat-Santos IJ; Santos-Martínez S; Julca F; Catalá P; Rodríguez-Gabella T; Redondo-Diéguez A; Hinojosa W; Veras C; Campo A; Serrador Frutos A; Carrasco-Moraleja M; San Román JA
Rev Esp Cardiol (Engl Ed); 2021 May; 74(5):421-426. PubMed ID: 32402685
[TBL] [Abstract][Full Text] [Related]
4. Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation.
Kaewkes D; Ochiai T; Flint N; Patel V; Mahani S; Kim I; Patel D; Salseth T; Friedman M; Yoon SH; Singh S; Chakravarty T; Nakamura M; Cheng W; Makkar R
Am J Cardiol; 2021 Feb; 141():62-71. PubMed ID: 33221263
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.
Ochiai T; Saito S; Yamanaka F; Shishido K; Tanaka Y; Yamabe T; Shirai S; Tada N; Araki M; Naganuma T; Watanabe Y; Yamamoto M; Hayashida K
Heart; 2018 Apr; 104(8):644-651. PubMed ID: 28986405
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of impact of renin-angiotensin system inhibitors on survival after transcatheter aortic valve implantation.
Takagi H; Kuno T; Hari Y; Nakashima K; Yokoyama Y; Ueyama H; Ando T;
Minerva Cardiol Angiol; 2021 Jun; 69(3):299-309. PubMed ID: 33703852
[TBL] [Abstract][Full Text] [Related]
8. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial.
Liao YB; Xia C; Cheng Y; Li Q; Wei X; Ou Y; Chen F; Li Y; Liu Q; Xiong T; Zhao Z; Peng Y; Wei J; Feng Y; Chen M
Trials; 2021 Jul; 22(1):462. PubMed ID: 34275476
[TBL] [Abstract][Full Text] [Related]
10. Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.
Cubeddu RJ; Murphy SME; Asher CR; Garcia SA; Granada JF; Don CW; Patel S; Albaghdadi MS; Cavalcante JL; Coylewright M; Hahn RT; Genereux P; Yadav PK; Thourani VH; Leon MB
Am Heart J; 2023 Apr; 258():27-37. PubMed ID: 36596333
[TBL] [Abstract][Full Text] [Related]
11. Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis.
Andersson C; Abdulla J
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):21-27. PubMed ID: 27615013
[TBL] [Abstract][Full Text] [Related]
12. Impact of renin-angiotensin system blocker after aortic valve replacement-a systematic review and meta-analysis.
Zeng L; Li J; Yang J; Liao Y; Chen M
Ann Palliat Med; 2021 Feb; 10(2):1244-1252. PubMed ID: 33040553
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
Martinsson A; Törngren C; Nielsen SJ; Pan E; Hansson EC; Taha A; Jeppsson A
Heart; 2024 Jan; 110(3):202-208. PubMed ID: 37460192
[TBL] [Abstract][Full Text] [Related]
14. Effects of Statins After Transcatheter Aortic Valve Implantation in Key Patient Populations.
Fischer-Rasokat U; Renker M; Bänsch C; Weferling M; Liebetrau C; Herrmann E; Liakopoulos O; Choi YH; Hamm CW; Kim WK
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e669-e674. PubMed ID: 34321397
[TBL] [Abstract][Full Text] [Related]
15. Relation Between Renin-Angiotensin System Blockers and Survival Following Isolated Aortic Valve Replacement for Aortic Stenosis.
Magne J; Guinot B; Le Guyader A; Bégot E; Marsaud JP; Mohty D; Aboyans V
Am J Cardiol; 2018 Feb; 121(4):455-460. PubMed ID: 29254679
[TBL] [Abstract][Full Text] [Related]
16. Association between renin-angiotensin-aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort.
Park CS; Kim B; Rhee TM; Lee HJ; Lee HS; Park JB; Kim YJ; Han KD; Kim HK
Clin Res Cardiol; 2023 Nov; 112(11):1577-1586. PubMed ID: 36867200
[TBL] [Abstract][Full Text] [Related]
17. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
[TBL] [Abstract][Full Text] [Related]
18. Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
Brízido C; Madeira M; Brito J; Madeira S; Campante Teles R; Raposo L; Mesquita Gabriel H; Nolasco T; de Araújo Gonçalves P; Sousa-Uva M; Abecasis M; de Sousa Almeida M; Neves JP; Mendes M
Catheter Cardiovasc Interv; 2021 Dec; 98(7):E1033-E1043. PubMed ID: 34506074
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy after surgical aortic valve replacement for aortic regurgitation.
Törngren C; Jonsson K; Hansson EC; Taha A; Jeppsson A; Martinsson A
Eur J Cardiothorac Surg; 2023 May; 63(5):. PubMed ID: 36748999
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
Goel SS; Aksoy O; Gupta S; Houghtaling PL; Tuzcu EM; Marwick T; Mihaljevic T; Svensson L; Blackstone EH; Griffin BP; Stewart WJ; Barzilai B; Menon V; Kapadia SR
Ann Intern Med; 2014 Nov; 161(10):699-710. PubMed ID: 25402513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
